Canadian Mass Spectrometry Veteran, Paul Taylor, Joins Rapid Novor Inc.
Rapid Novor Inc., the world’s leader in antibody protein sequencing using mass spectrometry, today announces that the Canadian mass spectrometry veteran, Mr. Paul Taylor has joined the team as the Core Facility Manager.
Prior to joining Rapid Novor, Mr. Taylor has been the Manager and Senior Proteomics Specialist at SPARC BioCentre, The Hospital for Sick Children in Toronto, for the past ten years. He was also formerly a Principle Scientist at MDS-Proteomics, and the Director of Laboratory Operations at Protana Analytical Services. In the past 20 years, he has been responsible for the planning and set up of the mass spectrometry facilities for multiple centres in Canada. He has published in leading peer-reviewed journals such as International Journal of Cancer, Cell, and Nature.
“We are thrilled to have such an accomplished mass spectrometry veteran joining our team”, says Mingjie Xie, co-founder and CEO. “We are at the stage of scaling up our REmAb™ antibody protein sequencing service. Mr. Taylor’s experiences and expertise will ensure that our mass spectrometry lab is running smoothly at high throughput to meet the growing customer’s needs.”
“Mr. Taylor has been a long time adviser to our company”, says Dr. Bin Ma, co-founder and Chief Scientist. “Now with his joining in full-time and the several key hires in the past year, we have built a dream team in proteomics. I have great confidence in the team in fulfilling our mission: to advance life science for better human health with next generation protein sequencing.”
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics